Stamper Christopher E, Hassell James E, Kapitz Adam J, Renner Kenneth J, Orchinik Miles, Lowry Christopher A
a Department of Integrative Physiology and Center for Neuroscience , University of Colorado Boulder , Boulder , CO , USA.
b Department of Biology , University of South Dakota , Vermillion , SD , USA.
Stress. 2017 Mar;20(2):223-230. doi: 10.1080/10253890.2017.1301426. Epub 2017 Mar 27.
Acute activation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to the release of corticosteroid hormones into the circulation, is an adaptive response to perceived threats. Persistent activation of the HPA axis can lead to impaired physiological or behavioral function with maladaptive consequences. Thus, efficient control and termination of stress responses is essential for well-being. However, inhibitory control mechanisms governing the HPA axis are poorly understood. Previous studies suggest that serotonergic systems, acting within the medial hypothalamus, play an important role in inhibitory control of stress-induced HPA axis activity. To test this hypothesis, we surgically implanted chronic jugular cannulae in adult male rats and conducted bilateral microinjection of vehicle or the 5-HT receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide (8-OH-DPAT; 8 nmol, 0.2 μL, 0.1 μL/min, per side) into the dorsomedial hypothalamus (DMH) immediately prior to a 40 min period of restraint stress. Repeated blood sampling was conducted using an automated blood sampling system and plasma corticosterone concentrations were determined using enzyme-linked immunosorbent assay. Bilateral intra-DMH microinjections of 8-OH-DPAT suppressed stress-induced increases in plasma corticosterone within 10 min of the onset of handling prior to restraint and, as measured by area-under-the-curve analysis of plasma corticosterone concentrations, during the 40 min period of restraint. These data support an inhibitory role for serotonergic systems, acting within the DMH, on stress-induced activation of the HPA axis. Lay summary: Inhibitory control of the hypothalamic-pituitary-adrenal (HPA) stress hormone response is important for well-being. One neurochemical implicated in inhibitory control of the HPA axis is serotonin. In this study we show that activation of serotonin receptors, specifically inhibitory 5-HT receptors in the dorsomedial hypothalamus, is sufficient to inhibit stress-induced HPA axis activity in rats.
下丘脑-垂体-肾上腺(HPA)轴的急性激活会导致皮质类固醇激素释放到循环系统中,这是对感知到的威胁的一种适应性反应。HPA轴的持续激活会导致生理或行为功能受损,并产生适应不良的后果。因此,有效控制和终止应激反应对于身心健康至关重要。然而,目前对调节HPA轴的抑制性控制机制了解甚少。先前的研究表明,作用于下丘脑内侧的血清素能系统在抑制应激诱导的HPA轴活动中起重要作用。为了验证这一假设,我们给成年雄性大鼠手术植入慢性颈静脉插管,并在40分钟的束缚应激之前,立即将溶剂或5-羟色胺受体激动剂8-羟基-2-(二正丙基氨基)四氢萘溴化物(8-OH-DPAT;8 nmol,0.2 μL,0.1 μL/分钟,每侧)双侧微量注射到背内侧下丘脑(DMH)。使用自动采血系统进行重复采血,并使用酶联免疫吸附测定法测定血浆皮质酮浓度。双侧DMH内微量注射8-OH-DPAT可在束缚前处理开始后10分钟内抑制应激诱导的血浆皮质酮升高,并且通过血浆皮质酮浓度的曲线下面积分析测量,在40分钟的束缚期内也有抑制作用。这些数据支持了血清素能系统在DMH内对应激诱导的HPA轴激活具有抑制作用。通俗总结:下丘脑-垂体-肾上腺(HPA)应激激素反应的抑制性控制对身心健康很重要。血清素是一种与HPA轴抑制性控制有关的神经化学物质。在本研究中,我们表明血清素受体的激活,特别是背内侧下丘脑的抑制性5-羟色胺受体的激活,足以抑制大鼠应激诱导的HPA轴活动。